The question I get most in private messages is simple: how high is the Ukraine IVF success rate? I usually refuse to throw out a percentage first, because two people can both say Ukraine IVF and be living in totally different statistics. A 35-year-old using her own eggs in a fresh transfer is not playing the same game as a 43-year-old using donor sperm and moving into a surrogacy process. Age, ovarian reserve and sperm source have to be lined up before any number means anything. What follows is the practical version I wish someone had handed me earlier, with the figures I actually ask clinics to put in writing.
Age changes the answer more than the clinic brand
For patients under 35 using own eggs, several Ukraine centers publicly quote clinical pregnancy rates around 45% to 55% per transfer. By 38 to 40, that same number often slides closer to 30%. After 42 with autologous eggs, 10% to 15% is the honest range I plan around, not the brochure range. That gap can be 30 percentage points between a 35-year-old and a 42-year-old asking the same question in the same waiting room.
A useful rule before any cycle: state your age, AMH and antral follicle count before asking for success rate. I remember a 41-year-old with AMH 0.9 who had two stimulations in China and produced three eggs total. In Ukraine the doctor did not sugarcoat it: with the same hotel stay, injections and emotional runway, cumulative live birth with her own eggs was under 20%. She pushed for one own-egg attempt anyway, got five eggs, one blastocyst and no implantation. The second plan finally matched biology.
Before signing anything, ask the agency or clinic to write this line into the plan: for your age band, AMH range and diagnosis, how many transfers and live births did this center record in the last 12 months? If they answer with one polished total success rate, they are dancing.
Donor sperm: three report lines matter more than height
Families choosing donor sperm often get pulled toward height, education and baby photos. Those are branding. The report should be judged by three colder items. First, concentration and motility: I like to see concentration at or above 40 million per ml and progressive motility at or above 50%, not vague excellent quality. Second, infectious and genetic screening should be complete: HIV, hepatitis B and C, syphilis, plus thalassemia and cystic fibrosis where relevant. Third, the sample must come from a traceable, compliant bank.
In Ukraine, some centers work with European sperm banks, and thaw survival is commonly listed around 60% to 70%. That number is not trivia; it feeds directly into fertilization rate and how many usable embryos remain on day five. I saw a couple in a hurry accept unclear sample paperwork. Seven eggs fertilized, only two embryos made it to transfer, and the transfer failed. The cheap shortcut became an expensive lost cycle.
Do this immediately: when donor material is proposed, request the sample ID, the full screening list and the stated thaw survival rate. If one is missing, change the source. It feels fussy now; it feels cheap after a failed cycle.
Surrogacy steps: the middle two phases eat the calendar
Many people picture surrogacy as sign, transfer, baby. The real sequence is longer: medical evaluation and document preparation take about one to two months; matching with a surrogate takes one to four months; legal contract and parentage paperwork take another one to two months; then transfer plus pregnancy runs about nine months after transfer. Total is commonly 12 to 18 months, and the delay is usually in matching and legal documents, not transfer day.
I tracked one case where matching took three and a half months. The intended parents wanted a specific blood type, no smoking, stable home life and a recent clean medical history. Only two candidates passed the first screen, and one was removed after thyroid labs came back abnormal. Nothing dramatic happened; the calendar simply did what calendars do.
So do not budget as if all risk lands on transfer day. Ask for a monthly surrogate-candidate progress sheet: how many screened, how many passed medical review, where contracts stand and the expected signature week. If a team cannot produce that table, later delays become mysteries you pay for emotionally and financially.
Blastocyst rate: it is not the machine list
Laboratory quality decides what happens between retrieval day and transfer day. Industry ballpark for blastocyst formation is roughly 40% to 55%; strong labs push toward 60%, weaker ones sit near 35%. The difference is rarely the brand on the incubator. It is the embryologist’s judgement habit, how strictly they call arrest, and the rhythm of media changes, gas settings and daily review.
I once compared two reports from the same retrieval number: 12 eggs. One lab produced six usable blastocysts; the other produced three, with two of them graded generously in my opinion. Same diagnosis, similar age, very different day-five shelf. This is why I ask how many eggs were mature, how many fertilized normally, how many reached blastocyst, how many were biopsied if doing PGT, and how many were actually frozen. A clinic that only reports pregnancy rate is showing you the scoreboard while hiding the innings.
Treat every percentage as a question, not a promise. Ukraine IVF can be efficient, transparent and well priced, but only when age, donor sperm paperwork, surrogate pipeline and lab metrics are pulled into one table. Get the numbers in writing, then compare clinics like a skeptic with a calendar, not a tourist with a hope.